STOCK TITAN

Inflection Point Financials

IPCXR
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Inflection Point (IPCXR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI IPCXR FY2025

FY2025 was shaped more by financing-driven balance-sheet movement than by self-funding operations or steady operating earnings.

The most telling disconnect is that net income turned positive at $498K even though operating income stayed negative at -$6.5M. With operating cash flow also negative at -$1.4M, FY2025's reported profit looks driven by items outside the recurring expense base, so accounting earnings and cash economics were not moving together.

The balance sheet sends mixed signals: short-term liquidity improved from near-zero in FY2024 to 2.8x in FY2025. At the same time, negative equity widened from -$61K to -$13.7M, so easier bill-paying did not translate into stronger net worth.

Cash deployment in FY2025 was dominated by financing and investing flows, with $255.3M raised and $252.8M sent into investments. Because operations still used cash, the larger asset base appears to reflect capital placement around the business rather than cash generated by the business itself.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 10 / 100
Financial Profile 10/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Inflection Point's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
8

Inflection Point has an operating margin of -6.5%, meaning the company retains $-7 of operating profit per $100 of revenue. This below-average margin results in a low score of 8/100, suggesting thin profitability after operating expenses.

Liquidity
54

Inflection Point's current ratio of 2.84 indicates adequate short-term liquidity, earning a score of 54/100. The company can meet its near-term obligations, though with limited headroom.

Piotroski F-Score Weak
3/9

Inflection Point passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality Low Quality
-2.89x

For every $1 of reported earnings, Inflection Point generates $-2.89 in operating cash flow (-$1.4M OCF vs $498K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$100.0M

Inflection Point generated $100.0M in revenue in fiscal year 2025.

EBITDA
N/A
Net Income
$498K
YoY+680.9%

Inflection Point reported $498K in net income in fiscal year 2025. This represents an increase of 680.9% from the prior year.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$1.1M

Inflection Point held $1.1M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
N/A

Margins & Returns

Gross Margin
N/A
Operating Margin
-6.5%

Inflection Point's operating margin was -6.5% in fiscal year 2025, reflecting core business profitability.

Net Margin
0.5%

Inflection Point's net profit margin was 0.5% in fiscal year 2025, showing the share of revenue converted to profit.

Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

IPCXR Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q1'24
Revenue $100.0M N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $627K N/A $2.8M+493.4% $467K+481.7% $80K N/A $17K+179.6% $6K
Operating Income -$627K N/A -$2.8M-493.4% -$467K-481.7% -$80K N/A -$17K-179.6% -$6K
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income $1.7M N/A -$91K+92.5% -$1.2M-1415.4% -$80K N/A -$17K-179.6% -$6K
EPS (Diluted) N/A N/A N/A N/A N/A N/A N/A N/A

IPCXR Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q1'24
Total Assets $263.2M+0.8% $261.1M+0.8% $259.1M+0.9% $256.7M+47860.1% $535K+64.2% $326K N/A N/A
Current Assets $1.1M-17.4% $1.3M-12.6% $1.5M-43.5% $2.6M+30406.8% $9K+56.1% $6K N/A N/A
Cash & Equivalents $835K-25.9% $1.1M-11.4% $1.3M-15.8% $1.5M N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $277.2M+0.9% $274.8M+1.0% $272.1M+1.9% $267.0M+39371.2% $676K+74.9% $387K N/A N/A
Current Liabilities $312K-32.0% $458K+7.8% $425K+68.6% $252K-60.9% $644K+72.9% $372K N/A N/A
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$14.0M-2.8% -$13.7M-4.8% -$13.0M-27.0% -$10.3M-7173.0% -$141K-132.1% -$61K-2723.9% $2K-87.8% $19K
Retained Earnings -$14.0M-2.8% -$13.7M-4.8% -$13.0M-27.0% -$10.3M-6079.1% -$166K-93.6% -$86K N/A N/A

IPCXR Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q1'24
Operating Cash Flow -$225K+45.8% -$415K-38.6% -$299K N/A N/A N/A N/A N/A
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A $250K $0 N/A N/A N/A N/A N/A
Financing Cash Flow -$67K-428.2% $20K-66.3% $60K N/A N/A N/A N/A N/A
Dividends Paid $300.0M $0 N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

IPCXR Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q1'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin -0.6% N/A N/A N/A N/A N/A N/A N/A
Net Margin 1.7% N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A -721.1%-689.7pp -31.4%
Return on Assets 0.6% N/A -0.0%+0.4pp -0.5%+14.5pp -15.0% N/A N/A N/A
Current Ratio 3.45+0.6 2.84-0.7 3.50-7.0 10.46+10.4 0.010.0 0.01 N/A N/A
Debt-to-Equity -19.74+0.4 -20.11+0.8 -20.87+5.1 -26.01-21.2 -4.79+1.6 -6.36 N/A N/A
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$13.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Frequently Asked Questions

Inflection Point (IPCXR) reported $100.0M in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Yes, Inflection Point (IPCXR) reported a net income of $498K in fiscal year 2025, with a net profit margin of 0.5%.

Inflection Point (IPCXR) had an operating margin of -6.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Inflection Point (IPCXR) had a net profit margin of 0.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Inflection Point (IPCXR) generated -$1.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Inflection Point (IPCXR) had $261.1M in total assets as of fiscal year 2025, including both current and long-term assets.

Inflection Point (IPCXR) had a current ratio of 2.84 as of fiscal year 2025, which is generally considered healthy.

Inflection Point (IPCXR) had a debt-to-equity ratio of -20.11 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Inflection Point (IPCXR) had a return on assets of 0.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Inflection Point (IPCXR) had $1.1M in cash against an annual operating cash burn of $1.4M. This gives an estimated cash runway of approximately 9 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Inflection Point (IPCXR) has negative shareholder equity of -$13.7M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Inflection Point (IPCXR) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Inflection Point (IPCXR) has an earnings quality ratio of -2.89x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Inflection Point (IPCXR) scores 10 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top